IRIS

STEFANACHI, ANGELA

STEFANACHI, ANGELA  

DIPARTIMENTO DI FARMACIA-SCIENZE DEL FARMACO  

Mostra records
Risultati 1 - 20 di 86 (tempo di esecuzione: 0.075 secondi).
Titolo Data di pubblicazione Autore(i) File
(EN) GALLOYL BENZAMIDE-BASED COMPOUNDS AS JNK MODULATORS (FR) COMPOSES A BASE DE GALLOYL BENZAMIDE UTILISES EN TANT QUE MODULATEURS DE JNK 1-gen-2014 Cellamare, Saverio; Carotti, Angelo; Stefanachi, Angela; Leonetti, Francesco; Nicolotti, Orazio; Catto, Marco; Pisani, Leonardo; Tardia, Piero; Introcaso, Antonellina; Valentina, Leo; Addabbo, Francesco; Montagnani, Monica; Nacci, Carmela
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 1-gen-2008 Stefanachi, Angela; Nicolotti, Orazio; Leonetti, Francesco; Cellamare, Saverio; Campagna, Francesco; Loza, Mi; Brea, Jm; Mazza, F; Gavuzzo, E; Carotti, Angelo
1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships 1-gen-2009 Fernandez, F; Caamano, O; Nieto, Mi; Lopez, C; Garcia Mera, X; Stefanachi, Angela; Nicolotti, Orazio; Loza, Mi; Brea, J; Esteve, C; Segarra, V; Vidal, B; Carotti, Angelo
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor 1-gen-2008 Stefanachi, A; Brea, J. M.; Cadavid, M. I.; Centeno, N. B.; Esteve, C; Loza, M. I.; Martinez, A; Nieto, R; Raviña, E; Sanz, F; Segarra, V; Sotelo, E; Vidal, B.; Carotti, A
3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition 1-gen-2021 Majellaro, María; Jespers, Willem; Crespo, Abel; Núñez, María J; Novio, Silvia; Azuaje, Jhonny; Prieto-Díaz, Rubén; Gioé, Claudia; Alispahic, Belma; Brea, José; Loza, María I; Freire-Garabal, Manuel; Garcia-Santiago, Carlota; Rodríguez-García, Carlos; García-Mera, Xerardo; Caamaño, Olga; Fernandez-Masaguer, Christian; Sardina, Javier F; Stefanachi, Angela; El Maatougui, Abdelaziz; Mallo-Abreu, Ana; Åqvist, Johan; Gutiérrez-de-Terán, Hugo; Sotelo, Eddy
4-(ALKYL)AMINOMETHYL-SUBSTITUTED COUMARINS AS POTENT AND SELECTIVE ACHE AND MAO-B DUAL INHIBITORS WITH A THERAPEUTIC POTENTIAL IN NEURODEGENERATIVE DISORDERS 1-gen-2013 Pisani, Leonardo; Catto, Marco; Stefanachi, Angela; Leonetti, F; Campagna, Francesco; Nicolotti, O; SOTO OTERO, R; Carotti, A.
4-(Alkylamino)methyl-substituted coumarins as potent and selective AChE and MAO-B dual inhibitors with a therapeutic potential in neurodegenerative disorders 1-gen-2013 Pisani, L.; Catto, M.; Stefanachi, A.; Leonetti, F.; Campagna, F.; Nicolotti, O.; Soto-Otero, R.; Carotti, A.
8-Substituted- 9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B 1-gen-2004 Carotti, Angelo; Stefanachi, Angela; Ravina, E; Sotelo, E; Loza, Mi; Cadavid, Mi; Centeno, Nb; Nicolotti, Orazio
9-Deazaxanthines as selective A2B AR ligands: Design, Synthesis and SAFIR studies 1-gen-2003 Stefanachi, Angela
9-Deazaxanthines as selective A2B AR ligands: Design, Synthesis and SAFIR studies 1-gen-2004 Carotti, A; Cadavid, M. I.; Centeno, N. B.; Esteve, C; Fontaine, F; GUTIÉRREZ DE TERÁN, H; Loza, M. I.; Martinez, A; Nicolotti, Orazio; Nieto, R; Pastor, M; Raviña, E; Sanz, F; Segarra, V; Sotelo, E; Stefanachi, Angela
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. 1-gen-2010 Nicolotti, Orazio; Giangreco, I; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Cellamare, Saverio; Carotti, A.
A Multi-Objective Optimization Algorithm for Molecular Design 1-gen-2009 Giangreco, I; Nicolotti, Orazio; Miscioscia, T. F.; Convertino, M; Mangiatordi, G. F.; Siragusa, L; Catto, Marco; Leonetti, Francesco; Stefanachi, Angela; Carotti, A.
A multitarget approach in cancer research 1-gen-2009 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A multitarget approach in cancer research. Joint Meeting on Medicinal Chemistry 1-gen-2009 Leonetti, Francesco; Stefanachi, Angela; Pellegrino, G; Nicolotti, Orazio; Catto, Marco; Muncipinto, G; Carotti, A.
A novel strategy for the treatment of Hodgkin lymphoma 1-gen-2014 Stolfa, D.; Porcelli, L.; Quatrale, A. E.; Stefanachi, Angela; Iacobazzi, R. M.; Sidella, L.; Cellamare, Saverio; Azzariti, A.
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 1-gen-2022 Pisani, Leonardo; Catto, Marco; Muncipinto, Giovanni; Nicolotti, Orazio; Carrieri, Antonio; Rullo, Mariagrazia; Stefanachi, Angela; Leonetti, Francesco; Altomare, Cosimo
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation 1-gen-2009 Stolfa, A; Cellamare, Saverio; Stefanachi, Angela; Catto, Marco; Leonetti, Francesco; Nicolotti, Orazio; Carotti, A.
Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to 1-gen-2020 Carofiglio, F.; Trisciuzzi, D.; Gambacorta, N.; Leonetti, F.; Stefanachi, A.; Nicolotti, O.
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile 1-gen-2011 Leonetti, Francesco; Stefanachi, Angela; Nicolotti, Orazio; Catto, Marco; Pisani, Leonardo; Cellamare, Saverio; Carotti, Angelo
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 1-gen-2020 Carofiglio, F.; Lopalco, A.; Lopedota, A.; Cutrignelli, A.; Nicolotti, O.; Denora, N.; Stefanachi, A.; Leonetti, F.